Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (5): 828-832    DOI: 10.31083/j.ejgo.2020.05.5474
Case Report Previous articles | Next articles
Metastatic mesonephric adenocarcinoma of unknown origin after hysterectomy: A case report
Youngsun Kim1, *(), Sungkyoung Moon2, Kiyong Na3
1Department of Obstetrics and Gynecology, Kyung Hee Medical Center, College of Medicine, Kyung Hee University, Seoul, Republic of Korea
2Department of Radiology, Kyung Hee Medical Center, College of Medicine, Kyung Hee University, Seoul, Republic of Korea
3Department of Pathology, Kyung Hee Medical Center, College of Medicine, Kyung Hee University, Seoul, Republic of Korea
Download:  PDF(1036KB)  ( 164 ) Full text   ( 10 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Müllerian and Wolffian ducts originate from the mesodermal tissue. In females, the Müllerian ducts develop to form the fallopian tubes, uterus, cervix, and upper two-thirds of the vagina; whereas in males, they regress. The Wolffian duct, also called the mesonephric duct, regresses in females during development. Mesonephric carcinomas occur through the female genital tract, and the majority arise in the cervix of the uterus. We report the case of a patient who had abdominal pain 4 weeks prior to admission, and who underwent a hysterectomy 20 years prior. The radiologic results revealed a 6.7 × 5.4 × 4.3 cm-sized mass in the retroperitoneum but were not indicative of mesonephric adenocarcinoma. The patient underwent complete mass surgical resection, followed by posterior sectionectomy of the liver and splenectomy with cholecystectomy. The histopathologic results showed that the mass was a mesonephric adenocarcinoma.
Key words:  Hysterectomy      Mesonephric adenocarcinoma      Metastatic      Pelvic mass      Unknown origin     
Submitted:  12 February 2020      Accepted:  01 April 2020      Published:  15 October 2020     
*Corresponding Author(s):  YOUNGSUN KIM     E-mail:  chacha0725@naver.com

Cite this article: 

Youngsun Kim, Sungkyoung Moon, Kiyong Na. Metastatic mesonephric adenocarcinoma of unknown origin after hysterectomy: A case report. European Journal of Gynaecological Oncology, 2020, 41(5): 828-832.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.05.5474     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I5/828

[1] John P. Micha, Howard D. Epstein, Michael C. Roossin, Randy Bohart, Mark A. Rettenmaier, Bram H. Goldstein. Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage iva cervical carcinoma[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 797-801.
[2] Adrius Gaurilcikas, Migle Gedgaudaite, Saulius Paskauskas, Tomas Birzietis, Daiva Vaitkiene. Unusual case of Krukenberg tumors diagnosed in early pregnancy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 806-809.
[3] Sun Yi Choe, Jung-Woo Park. Prognostic significance of the number of metastatic lymph nodes in early cervical cancer: a retrospective study[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 536-540.
[4] Terumi Tanigawa, Maki Matoda, Yoichi Aoki, Hidetaka Nomura, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao, Nobuhiro Takeshima. A case of recurrent smooth muscle tumor of uncertain malignant potential with abdominal dissemination after morcellation[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 648-650.
[5] Mustafa Ayhan Ekici, Ali Can Onal, Caglar Cetin. Likelihood of incidental finding of gynecological cancer in women undergoing hysterectomy for benign indications[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 402-407.
[6] I. Ferreira, C. Estevinho, A. Torgal, C. Carrapatoso, F. Costa. Should we search for high-risk HPV in vaginal vault Pap smear after hysterectomy due to CIN2+?[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 157-162.
[7] X. Zhang, Y. Fu, X. Zhang, J. Ding, K. Hua. The effect of transcutaneous electrical stimulation treatment in combination with intraoperative nerve staining on sexual function after radical hysterectomy: a pilot study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 188-191.
[8] M.F. Benoit. Concordance of adnexal mass laterality: from preoperative imaging to surgical pathologic findings[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 252-255.
[9] M. Sakaguchi, T. Maebayashi, T. Aizawa, N. Ishibashi, T. Saito. High-dose-rate intracavitary brachytherapy for non-palpable and non-visible recurrent vaginal stump tumors after hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 54-59.
[10] H.Ç. Özcan, Ö. Balat, M.G. Uğur, S. Sucu, N.B. Tepe, Ö.K. Karusercï, Z. Bozdağ. Extraperitoneal pelvic lymph node dissection with laparotomy in occult invasive cervical cancer found after a simple hysterectomy[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 982-987.
[11] E. Kertowidjojo, O. Taha, M. Pearl, R. Batiste, A. Kudelka. A case of metastatic mixed trophoblastic tumor[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1024-1026.
[12] P.-S. Huang, C.-T. Yue, W.-Y. Kao, J.-M. Hwang, H.-W. Kuo, S.-C. Huang. Undifferentiated endometrial sarcoma of the cervix: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1035-1038.
[13] J. Klat, O. Simetka, C. Povysil. Cervical leiomyosarcoma treated by radical laparoscopic approach: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1093-1095.
[14] Yangyang Shi, Yongyun Shi, Dabao Wu. A case of placental site trophoblastic tumor and a retrospective analysis[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1096-1099.
[15] R. Du, L. Li, S. Ma, X. Tan, S. Zhong, M. Wu. Survival outcomes of Stage IB cervical cancer treated with standard radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 810-814.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] B. Soltész, J. Lukács, A. Penyige, R. Póka, B. Nagy. Determination of miR-193b rs30236 single nucleotide polymorphism in ovarian cancer patients[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 547 -550 .
[3] Y. Li, C. Li, N. Li, L. Jiang, W. Yang, Y. Wang, B. Wu, C. Shi, Z. Zhu. RNAi silenced NUP88 gene suppresses growth and invasiveness of human breast cancer cell line MCF-7[J]. European Journal of Gynaecological Oncology, 2019, 40(4): 634 -639 .
[4] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[5] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .
[6] Z. Protrka, P. Arsenijevic, N. Jovic, S. Zivanovic, J. Djuric, A. Dimitrijevic. A case of uterine torsion in term pregnancy associated with placental abruption and intrauterine fetal demise[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(2): 287 -289 .
[7] T. Ueno, H. Yabushita, K. Iwasaki, A. Wakatsuki. Role of adiponectin and leptin in non-diabetic, non-obese patients with endometrial cancer[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 199 -204 .
[8] P. Pimsi, W. Santimaleeworagun, S. Therasakvichya, N. Saengsukkasemsak, A. Laocharoenkeat. The incidence and risk factors of severe neutropenia and febrile neutropenia due to chemotherapy among gynecologic cancer patients in Thailand[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 242 -246 .
[9] F. Lai-Tiong. Dermatomyositis revealing a 18-year breast cancer recurrence[J]. European Journal of Gynaecological Oncology, 2018, 39(2): 292 -293 .
[10] M.F. Benoit, K.A. O'Hanlan, M.S. Sten, C.L. Kosnik, D.M. Struck, M.S. O'Holleran, J. Cuff, D.M. Halliday, E.A. Kent. Incidental appendectomy at the time of gynecologic surgery[J]. European Journal of Gynaecological Oncology, 2018, 39(3): 386 -389 .